MedTrace Logo

Bioavailability Evaluation of CurQ+ Curcumin Formulation

NCT06177483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-09-19

No results posted yet for this study

Summary

This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men \& women.

Conditions

  • Bioavailability

Interventions

DIETARY_SUPPLEMENT

95% curcumin extract powder

95% curcumin extract powder

DIETARY_SUPPLEMENT

curQ+ curcumin formulation

curQ+ curcumin formulation

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • ESM Technologies, LLC

    lead INDUSTRY

Principal Investigators

  • Karen L Posey, PhD · UTHealth

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-04-05
Completion
2024-09-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06177483 on ClinicalTrials.gov